87S:FRA
Roivant Sciences Ltd
€29.67
0.00%
(0.00) 1D
Oct 19, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 87S...
Open
€29.60
High
€29.67
Low
€29.60
Mkt. cap
25.06B
Avg. vol.
25.00
Volume
0.00
52-wk high
€35.82
52-wk low
€14.34
No. of employees
721
Open
€29.60
High
€29.67
Low
€29.60
Mkt. cap
25.06B
Avg. vol.
25.00
Volume
0.00
52-wk high
€35.82
52-wk low
€14.34
No. of employees
721
News stories
From web sources and news partners
investingLive
·
27 minutes ago
Nasdaq and S&P rebounds; Dow slips
Traders Union
·
20 minutes ago
Sherwin-Williams rebound signals improving momentum for Dow stock
TradingView
·
49 minutes ago
There is no fundamental reason for stocks’ reversal, says SA analyst
Investing.com
·
23 minutes ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd